SCHEMBL1628699

SCHEMBL1628699

C[C@](C#N)(CCC(=O)O)N=N[C@](C)(C#N)CCC(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 1/20 0.38
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
THRB P10828 1/20 0.35
KMT2A Q03164 1/20 0.35
ESR1 P03372 1/20 0.35
CYP3A4 P08684 1/20 0.35
ESR2 Q92731 1/20 0.35
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
FFAR3 O14843 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
LMNA P02545 2/20 0.32
ALKBH5 Q6P6C2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL5680211 1.00 NAALAD2 (0.38) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL786277 1.00 NAALAD2 (0.38) NAALAD2ALDH1A1MEN1CYP1A2THRB
Hydrogen Peroxide SCHEMBL5680213 1.00 NAALAD2 (0.38) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL27673 1.00 NAALAD2 (0.38) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL27672 1.00 NAALAD2 (0.38) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL17181746 0.98 NAALAD2 (0.37) NAALAD2ALDH1A1MEN1CYP1A2THRB
SCHEMBL5885424 0.98 NAALAD2 (0.37) NAALAD2ALDH1A1MEN1CYP1A2THRB
Ammonia Solution, Strong SCHEMBL4143583 0.98 NAALAD2 (0.37) NAALAD2ALDH1A1MEN1CYP1A2THRB
Potassium SCHEMBL9577411 0.98 NAALAD2 (0.37) NAALAD2ALDH1A1MEN1CYP1A2THRB
Ammonia Solution, Strong SCHEMBL29966095 0.98 NAALAD2 (0.37) NAALAD2ALDH1A1MEN1CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250215131-A1 POLYMER/CELLULOSE NANOCRYSTAL-BASED NANOCOMPOSITE AND METHOD OF MAKING SAME NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY 2025-07-03 US claimed
WO-2023244814-A1 POLYMER/CELLULOSE NANOCRYSTAL-BASED NANOCOMPOSITE AND METHOD OF MAKING SAME FOX DOUGLAS (US) 2023-12-21 WO claimed
US-20220098226-A1 METHODS OF PREPARING STEVIOL GLYCOSIDES AND USES OF THE SAME PURECIRCLE USA INC. 2022-03-31 US claimed
CN-111836545-A Method for preparing steviol glycoside and application thereof 谱赛科美国股份有限公司 2020-10-27 CN claimed
EP-3687296-A1 METHODS OF PREPARING STEVIOL GLYCOSIDES AND USES OF THE SAME PureCircle USA Inc. (US) 2020-08-05 EP claimed
WO-2019067812-A1 METHODS OF PREPARING STEVIOL GLYCOSIDES AND USES OF THE SAME PURECIRCLE USA INC. (US) 2019-04-04 WO claimed
US-20180079767-A1 METHODS OF PREPARING STEVIOL GLYCOSIDES AND USES OF THE SAME PURECIRCLE USA INC. 2018-03-22 US claimed
CN-122029245-A Use of a composition for improving adhesive bonding of surfaces and method for bonding surfaces 法国特种经营公司 2026-05-12 CN disclosed
US-12589077-B2 Method for preparing biodegradable microcapsules and microcapsules thus obtained GEM INNOV (FR) 2026-03-31 US disclosed
EP-4706112-A1 COMPOSITION FOR THE PREPARATION OF A CATHODE PRIMING COAT Coatex (FR) 2026-03-11 EP disclosed
EP-4706111-A1 PREPARATION OF A CATHODE PRIMING COAT COATEX (FR) 2026-03-11 EP disclosed
US-20250346836-A1 CONSUMER PRODUCT COMPOSITIONS COMPRISING A POPULATION OF ENCAPSULATES PROCTER & GAMBLE (US) 2025-11-13 US disclosed
US-20250282621-A1 CARBON NANOTUBE COMPOSITE COMPRISING MECHANICAL L IGANDS NANOCORE APS (DK) 2025-09-11 US disclosed
US-6150573-A Concurrent production of trichloroethane isomers PPG INDUSTRIES OHIO, INC. (US) 2000-11-21 US disclosed
US-5731482-A Method for purifying perchloroethylene containing dichlorobutadiene PPG INDUSTRIES, INC. (US) 1998-03-24 US disclosed
US-5382727-A Free radical chlorination of 1,1-dichloroethane PPG INDUSTRIES, INC. (US) 1995-01-17 US disclosed
US-5315052-A Concurrent production of trichloroethane isomers PPG INDUSTRIES, INC. (US) 1994-05-24 US disclosed
US-5298646-A Introducing molecular chlorine to stripping zone, contacting ethyl chloroformate in rectifying zone, condensation, refluxing, removal of gaseous phase PPG INDUSTRIES, INC. (US) 1994-03-29 US disclosed
US-5051536-A Using a free radical catalyst to form cis-, trans-isomers PPG INDUSTRIES, INC. (US) 1991-09-24 US disclosed
WO-1991002708-A1 METHOD FOR ISOMERIZING 1,2-DICHLOROETHENE PPG INDUSTRIES, INC. (US) 1991-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589077-B2 Method for preparing biodegradable microcapsules and microcapsules thus obtained MYD88, MSMO1, ALOX5 NAALAD2 798/4885ALDH1A1 943/4885MEN1 2057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.